François Radvanyi Selected Research

Estrogen Receptors

4/2008

Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

François Radvanyi Research Topics

Disease

36	Neoplasms (Cancer) 04/2024 - 12/2004
30	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 03/2010
15	Carcinoma (Carcinomatosis) 04/2024 - 01/2003
5	Retinoblastoma (Glioblastoma, Retinal) 01/2023 - 01/2019
4	Non-Muscle Invasive Bladder Neoplasms 12/2023 - 09/2010
4	Breast Neoplasms (Breast Cancer) 03/2014 - 09/2008
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2010
2	Carcinogenesis 01/2023 - 01/2006
1	Ureteral Neoplasms (Ureteral Cancer) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Tertiary Lymphoid Structures 01/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Fibrosis (Cirrhosis) 12/2020
1	Necrosis 01/2019
1	Virus Diseases (Viral Diseases) 11/2018
1	Adenocarcinoma 11/2013
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2013
1	Carcinoma in Situ 01/2012
1	Noninfiltrating Intraductal Carcinoma (DCIS) 04/2008
1	Squamous Cell Carcinoma of Head and Neck 05/2007
1	Colorectal Neoplasms (Colorectal Cancer) 04/2007

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2006
11	Proteins (Proteins, Gene)FDA Link 06/2023 - 05/2006
8	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 12/2004
8	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 11/2020 - 01/2003
7	Phenobarbital (Luminal)FDA Link 11/2023 - 04/2008
4	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2011
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2022 - 12/2004
4	Messenger RNA (mRNA)IBA 10/2019 - 05/2005
4	ErbB Receptors (EGF Receptor)IBA 10/2015 - 05/2006
3	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2021
3	ChromatinIBA 11/2021 - 09/2006
3	ParaffinIBA 01/2020 - 04/2007
3	Small Interfering RNA (siRNA)IBA 03/2014 - 10/2009
2	LigandsIBA 06/2023 - 09/2017
2	CarcinogensIBA 01/2023 - 01/2005
2	Transcription Factors (Transcription Factor)IBA 01/2023 - 01/2023
2	Gemcitabine FDA Link 03/2020 - 01/2015
2	Phosphotransferases (Kinase)IBA 11/2018 - 09/2017
2	Growth Factor ReceptorsIBA 09/2017 - 03/2010
2	Formaldehyde (Formol)FDA Link 11/2016 - 04/2007
2	Protein Isoforms (Isoforms)IBA 03/2005 - 12/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023
1	uridylyl-(3'-5')-guanosineIBA 06/2023
1	phosphatidylinositol 3-phosphateIBA 01/2023
1	Mitochondrial DNA (mtDNA)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	Conditioned Culture MediaIBA 01/2022
1	CytokinesIBA 01/2022
1	Macrophage Migration-Inhibitory FactorsIBA 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 01/2022
1	Circulating Tumor DNAIBA 01/2021
1	InterferonsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	ProteomeIBA 01/2021
1	mesoglycanIBA 12/2020
1	Vinblastine (Vinblastine Sulfate)FDA Link 03/2020
1	Cisplatin (Platino)FDA LinkGeneric 03/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2020
1	Methotrexate (Mexate)FDA LinkGeneric 03/2020
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2020
1	KinesinsIBA 11/2019
1	c-Mer Tyrosine KinaseIBA 01/2019
1	Insulin (Novolin)FDA Link 09/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2017
1	Carrier Proteins (Binding Protein)IBA 09/2017
1	PlatinumIBA 01/2015
1	SaltsIBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 01/2015
1	DecorinIBA 12/2013
1	Histones (Histone)IBA 12/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2012
1	rab GTP-Binding ProteinsIBA 01/2012
1	Cadherins (E-Cadherin)IBA 03/2010
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2010
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 10/2009
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 09/2008
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 09/2008
1	Estrogen ReceptorsIBA 04/2008
1	Gefitinib (Iressa)FDA Link 05/2006
1	Tyrosine Kinase InhibitorsIBA 05/2006
1	Mitogen-Activated Protein KinasesIBA 05/2006
1	Viral DNAIBA 10/2005
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 12/2004
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 12/2004
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2004

Therapy/Procedure

12	Therapeutics 01/2022 - 10/2009
6	Cystectomy 12/2023 - 10/2019
4	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
3	Immunotherapy 01/2022 - 11/2016
2	Radiotherapy 08/2022 - 12/2020
1	Neoadjuvant Therapy 03/2020
1	Adjuvant Chemotherapy 03/2020